scholarly journals Fat Mass Index Better Identifies Metabolic Syndrome: Insights from Patients in Early Outpatient Cardiac Rehabilitation

2019 ◽  
Vol 8 (12) ◽  
pp. 2147
Author(s):  
Amanda R. Bonikowske ◽  
Maria Irene Barillas Lara ◽  
Katlyn E. Koepp ◽  
Jose R. Medina Inojosa ◽  
Ray W. Squires ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Cardiac Rehabilitation ◽  
Fat Mass ◽  
Cross Sectional Study ◽  
Dual Energy ◽  
Health Record ◽  
Sectional Study ◽  
Cross Sectional ◽  
Fat Mass Index ◽  
X Ray

Body mass index (BMI) does not differentiate fat and lean mass or the distribution of adipose tissue. The purpose of this study was to examine the prevalence of metabolic syndrome (MetS) among patients entering outpatient cardiac rehabilitation (CR) across fat mass index (FMI) categories compared with BMI. This retrospective cross-sectional study evaluated dual-energy x-ray absorptiometry in 483 CR patients from 1 January 2014, through 31 December 2017. Clinical data were extracted from the electronic health record. Patients were grouped by FMI and BMI categories. Mean (SD) age of patients was 64.3 (14) years. The normal FMI category had 15 patients; excess fat, 74; and obese, 384. In contrast, 93, 174, and 216 were in the normal, overweight, and obese BMI categories, respectively. Prevalence of MetS was 0 (0%) in normal, 5 (1%) in excess fat, and 167 (54%) in obese FMI, with 97% in the obese category. MetS prevalence was 4 patients (0.8%) in normal, 39 (8%) in overweight, and 129 (27%) in obese BMI categories, with 75% of MetS in the obese category. FMI more accurately classified CR patients with metabolically abnormal fat (p < 0.001). FMI is a more sensitive index than BMI for metabolically abnormal fat of outpatient CR patients.

The fat mass index, not the fat-free mass index, is associated with impaired physical performance in older adult subjects: Evidence from a cross-sectional study

2019 ◽  
Vol 38 (2) ◽  
pp. 877-882 ◽  
Author(s):  
Maribel Ramírez Torres ◽  
Roxana E. Ruiz Valenzuela ◽  
Julián Esparza-Romero ◽  
Miriam T. López Teros ◽  
Heliodoro Alemán-Mateo
Keyword(s):  
Older Adult ◽  
Physical Performance ◽  
Fat Mass ◽  
Cross Sectional Study ◽  
Fat Free Mass ◽  
Sectional Study ◽  
Cross Sectional ◽  
Fat Mass Index

Premature ovarian failure after childhood cancer and risk of metabolic syndrome – a cross-sectional analysis

2021 ◽  
Author(s):  
Axel Netterlid ◽  
Helena Mörse ◽  
Aleksander Giwercman ◽  
Emir Henic ◽  
Kristina E Akesson ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Childhood Cancer ◽  
Fasting Glucose ◽  
Childhood Cancer Survivors ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Ovarian Insufficiency ◽  
Cross Sectional ◽  
X Ray ◽  
Sectional Analysis

Objective: Female childhood cancer survivors (CCS) are at risk of several late effects, among them metabolic syndrome (MetS) and premature ovarian insufficiency (POI). The objective is to study if POI is associated with risk of MetS and increased cardiovascular risk in CSS. Design: A cross-sectional study with a median time since cancer diagnosis of 25 (12 – 41) years. Patients and controls were recruited from the South Medical Region of Sweden. Methods: The study included 167 female CCS, median age 34 (19 – 57) years, diagnosed with childhood cancer at median age 8.4 (0.1 – 17.9) years together with 164 controls, matched for age, sex, ethnicity, residence, and smoking habits. All subjects were examined with fasting glucose, insulin, HbA1c, and lipid profile. Fat mass was calculated with dual-energy X-ray absorptiometry (DXA), questionnaires for medication were obtained. Detailed information of cancer treatment was available. Results: POI was present in 13% (22/167) among CCS (hypothalamic/pituitary cause excluded) and in none among controls. MetS was present in 14% (24/167) among all CCS (p = 0.001), in 23% (5/22) of those with POI (p < 0.001), compared with 4% (6/164) among controls. OR for MetS in all CCS compared with controls was 4.4 (95% CI 1.8, 11.1) (p = 0.002) and among CCS with POI the OR was 7.7 (CI 2.1, 28.1) (p = 0.002). Conclusion: The prevalence of MetS was higher in females treated for childhood cancer compared with controls and the presence of POI significantly increased the risk of developing MetS.

Dual-energy X-ray absorptiometry at the lumbar spine in German men and women: A cross-sectional study

1995 ◽  
Vol 56 (5) ◽  
pp. 350-354 ◽  
Author(s):  
R. Lehmann ◽  
M. Wapniarz ◽  
O. Randerath ◽  
H. M. Kvasnicka ◽  
W. John ◽  
...  
Keyword(s):  
Lumbar Spine ◽  
Cross Sectional Study ◽  
Dual Energy ◽  
Sectional Study ◽  
Cross Sectional ◽  
Men And Women ◽  
X Ray

scholarly journals Assessment of Sarcopenia and Obesity in Patients with Myasthenia Gravis Using Dual-Energy X-ray Absorptiometry: A Cross-Sectional Study

2021 ◽  
Vol 11 (11) ◽  
pp. 1139
Author(s):  
Che-Cheng Chang ◽  
Yen-Kung Chen ◽  
Hou-Chang Chiu ◽  
Jiann-Horng Yeh
Keyword(s):  
Quality Of Life ◽  
Body Composition ◽  
Muscle Mass ◽  
Cross Sectional Study ◽  
Dual Energy ◽  
Sectional Study ◽  
Cross Sectional ◽  
X Ray ◽  
Composition Changes

Sarcopenia and obesity can negatively impact quality of life and cause chronic fragility, and are associated with neuromuscular diseases, including myasthenia gravis (MG). The long-term consequences of body composition changes in chronic MG remain unknown; we therefore evaluated changes in body composition, including sarcopenia, obesity, lean body mass, and the prevalence of sarcopenic obesity in patients. In this cross-sectional study, 35 patients with MG (mean age: 56.1 years) and 175 matched controls were enrolled. Body fat mass and skeletal muscle mass were measured using whole body dual-energy X-ray absorptiometry. Patients with MG exhibited a higher prevalence of obesity and higher android adiposity and total body fat percentage than those of controls. Although the prevalence of sarcopenia and sarcopenic obesity did not increase with age, there was a decrease in arm and android muscle mass in patients with MG compared with controls. Lower muscle mass percentages were correlated with increased age and MG severity, but not with corticosteroid use. Thus, MG is associated with increased risk for obesity and decreased muscle mass with aging, regardless of corticosteroid use. Therefore, accurate diagnosis of body composition changes in MG could facilitate the application of appropriate therapies to promote health, improve quality of life, and prevent fragility.

Sign in / Sign up

Export Citation Format

Share Document